Finn Sawyer Access to Cancer Testing Act

The Finn Sawyer Access to Cancer Testing Act requires Medicare, Medicaid, and the Children's Health Insurance Program (CHIP) to cover specific cancer diagnostic tests, including genetic sequencing (like DNA and RNA tests) and their interpretation, for individuals diagnosed with cancer. It defines these tests to include advanced genetic analysis methods and limits coverage to once at initial diagnosis, once at recurrence, and as needed for treatment planning or monitoring. The bill mandates that these tests be covered without a deductible under Medicare and requires states to include them in Medicaid and CHIP coverage starting January 1, 2025. Additionally, it establishes a federal education program to inform healthcare providers and the public about genomic testing for cancer care.